Literature DB >> 25923503

[Detecting inappropriate medication in older people: the revised STOPP/START criteria].

Wilma Knol1, Monique M Verduijn, A C A M Rian Lelie-van der Zande, Rob J van Marum, J R B J Koos Brouwers, Tischa J M van der Cammen, Mirko Petrovic, Paul A F Jansen.   

Abstract

The use of potentially inappropriate medications (PIMs) by older people and potential prescribing omissions (PPOs) represent a serious problem. It increases the risk of adverse drug reactions (ADRs), however it is susceptible to influence in a substantial number of cases. Use of the STOPP/START criteria developed in Ireland to optimise pharmacotherapy of older people reduces the number of ADRs and medication errors. Licensing of new drugs, the increased number of potentially inappropriate drugs, and the availability of new literature were grounds for an update of the first version of the STOPP/START criteria which was published in 2008. In order to develop a screening tool with a broader application, a consensus panel of experts in the field of pharmacotherapy of older people was selected from 14 European countries for the second version of the STOPP/START criteria, including two from the Netherlands. The translation of the second version of the STOPP/START criteria has been adapted to the situation in the Netherlands, partly by omitting drugs that are not licensed in the Netherlands.

Entities:  

Mesh:

Year:  2015        PMID: 25923503

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Inappropriate Prescriptions in Older People-Translation and Adaptation to Portuguese of the STOPP/START Screening Tool.

Authors:  Luís Monteiro; Matilde Monteiro-Soares; Cristiano Matos; Inês Ribeiro-Vaz; Andreia Teixeira; Carlos Martins
Journal:  Int J Environ Res Public Health       Date:  2022-06-04       Impact factor: 4.614

2.  An Interprofessional Student-Run Medication Review Program: The Clinical STOPP/START-Based Outcomes of a Controlled Clinical Trial in a Geriatric Outpatient Clinic.

Authors:  Rowan Sultan; Tessa O van den Beukel; Michael O Reumerman; Hester E M Daelmans; Hans Springer; Els Grijmans; Majon Muller; Milan C Richir; Michiel A van Agtmael; Jelle Tichelaar
Journal:  Clin Pharmacol Ther       Date:  2021-11-17       Impact factor: 6.903

3.  Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy.

Authors:  Marian Z M Hurmuz; Sarah I M Janus; Jeannette G van Manen
Journal:  Int J Clin Pharm       Date:  2018-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.